Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Seon Ho Ahn"'
Autor:
Hyunglae Kim, Seon A Jeong, Kyeong Min Kim, Sun Deuk Hwang, Sun Ryoung Choi, Hajeong Lee, Ji Hyun Kim, Su Hyun Kim, Tae Hee Kim, Ho-Seok Koo, Chang-Yun Yoon, Kiwon Kim, Seon Ho Ahn, Hye Eun Yoon, Yong Kyun Kim, Tae Hyun Ban, Yu Ah Hong
Publikováno v:
Kidney Research and Clinical Practice, Vol 43, Iss 3, Pp 263-273 (2024)
With an increasing aging population, the mean age of patients with end-stage kidney disease (ESKD) is globally increasing. However, the current clinical status of elderly patients undergoing hemodialysis (HD) is rarely reported in Korea. The current
Externí odkaz:
https://doaj.org/article/a40c6f47fccc4e32bc1ef5681a8caf5c
Autor:
Kyeong Min Kim, Seon A Jeong, Tae Hyun Ban, Yu Ah Hong, Seun Deuk Hwang, Sun Ryoung Choi, Hajeong Lee, Ji Hyun Kim, Su Hyun Kim, Tae Hee Kim, Ho-Seok Koo, Chang-Yun Yoon, Kiwon Kim, Seon Ho Ahn, Yong Kyun Kim, Hye Eun Yoon
Publikováno v:
Kidney Research and Clinical Practice, Vol 43, Iss 1, Pp 20-32 (2024)
This article provides an update of the trends and characteristics of diabetic kidney disease stage 5D (CKD 5D) patients according to the Korean Renal Data System (KORDS), a nationwide registry database operated by the Korean Society of Nephrology. Th
Externí odkaz:
https://doaj.org/article/d8c8fdd817d64d53b43c23869a0c3fc0
Publikováno v:
Kidney Research and Clinical Practice, Vol 40, Iss 1, Pp 120-134 (2021)
Background Larger middle molecules are important substances associated with cardiovascular complications in end- stage renal disease. Unfortunately, larger middle molecules are not reliably removed by a high -flux dialyzer. A medium cut-off (MCO) mem
Externí odkaz:
https://doaj.org/article/7ef3617117e5421aa0723585470d36ab
Publikováno v:
Kidney Research and Clinical Practice, Vol 37, Iss 1, Pp 30-40 (2018)
Background : Acute kidney injury (AKI) is a risk factor for progression to chronic kidney disease, with even subclinical AKI episodes progressing to chronic kidney disease. Several risk factors such as preexisting kidney disease, hyperglycemia, and h
Externí odkaz:
https://doaj.org/article/263c12a680dc4c2aa6434cf8c5a2f106
Autor:
Seon-Ho Ahn, Jong Hwan Jung
Publikováno v:
Kidney Research and Clinical Practice, Vol 39, Iss 2, Pp 228-229 (2020)
Externí odkaz:
https://doaj.org/article/e5d7c8679aa54657b7aab039e7f5aad0
Publikováno v:
Kidney Research and Clinical Practice, Vol 37, Iss 2, Pp 178-179 (2018)
Externí odkaz:
https://doaj.org/article/c5c0dcd081264bb98729adf469b26cd0
Publikováno v:
Kidney Research and Clinical Practice, Vol 40, Iss 1, Pp 120-134 (2021)
Kidney Research and Clinical Practice
Kidney Research and Clinical Practice
Background Larger middle molecules are important substances associated with cardiovascular complications in end- stage renal disease. Unfortunately, larger middle molecules are not reliably removed by a high -flux dialyzer. A medium cut-off (MCO) mem
Publikováno v:
Kidney Research and Clinical Practice, Vol 36, Iss 3, Pp 296-297 (2017)
Externí odkaz:
https://doaj.org/article/39f2406bdfd94ea89370e6028248149c
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Protein-bound toxins and uremic toxins with middle molecular weight usually develop uremic symptoms in patients with advanced chronic kidney disease (CKD) or end-stage renal disease (ESRD). Although the effect on uremic toxicity o
Autor:
Seon Ho Ahn, Jong Hwan Jung
Publikováno v:
Journal of Korean Medical Science